NAD+ × Peptide Partners - Lab Test, February 2026
Kovera Labs publishes a public verification portal. Any test attributed to this lab can be looked up and confirmed directly with the lab — so this result doesn't rest on our review alone.
Test results
About this test
This independent RP-HPLC certificate of analysis confirms Buffered NAD+ 750mg from Peptide Partners at 99.856% purity. The analysis was conducted by Kovera Labs on February 7, 2026 (Report #KVR-2026-727511).
Net content measured 869.24mg against a 750mg label claim. Identity was confirmed via LC-MS as NAD+ (C29H27N7O14P2, CAS 53-84-9). Endotoxin safety screening passed the reference standard (≤0.5 EU/mL), and heavy metals (Pb, Cd, As, Hg) all returned negative.
The full certificate of analysis is available for verification at koveralabs.com/verify using access code YNS8A76.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion
No comments yet. Sign in to be the first to discuss this test.